Understanding Risks and Benefits of New Cancer Drugs
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 3,000 (estimated)
- Sponsor
- London School of Economics and Political Science · Other
This trial is looking for adults in the U.S. who can share their thoughts on how new cancer drugs are communicated to them. Participants will help researchers understand how to better convey information about these drugs.
You may be able to join if
- I am 18 years old or older
- I speak English fluently
- I live in the United States
You may not be able to join if
- I do not meet all of the inclusion criteria
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Loading trial locations…